BILIRAKIS, BARRAGAN, CAMMACK, AUCHINCLOSS, KEAN & MULLIN INTRODUCE BIPARTISAN BILL TO PERMANENTLY PROTECT RARE PEDIATRIC DISEASE DRUG DEVELOPMENT PROGRAM -LEGISLATION PROVIDES LONG-TERM CERTAINTY TO ENCOURAGE INVESTMENT IN LIFESAVING TREATMENTS FOR CHILDR

Washington, Sept. 14 -- Congressman Gus Bilirakis issued the following press release:

Bilirakis, Barragan, Cammack, Auchincloss, Kean & Mullin Introduce Bipartisan Bill to Permanently Protect Rare Pediatric Disease Drug Development Program -Legislation Provides Long-Term Certainty to Encourage Investment in Lifesaving Treatments for Children with Rare Diseases- WASHINGTON, D.C. - Earlier today, U.S. Representatives Gus Bilirakis (R-FL), Nanette Barragan (D-CA), Kat Cammack (R-FL), Jake Auchincloss (D-MA), Tom Kean, Jr. (R-NJ) and Kevin Mullin (D-CA) introduced bipartisan legislation to permanently authorize the U.S. Food and Drug Administration's (FDA) Rare Pediatric Disease Priority Review Voucher (PRV) Program, an important incentive for...